These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 20397787)

  • 21. Association of insight with sociodemographic and clinical factors, quality of life, and cognition in Chinese patients with schizophrenia.
    Xiang YT; Wang Y; Wang CY; Chiu HF; Chen Q; Chan SS; Lai KY; Lee EH; Ungvari GS
    Compr Psychiatry; 2012 Feb; 53(2):140-4. PubMed ID: 21632041
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of negative symptoms in outpatients with schizophrenia spectrum disorders treated with antipsychotics in routine clinical practice: findings from the CLAMORS study.
    Bobes J; Arango C; Garcia-Garcia M; Rejas J;
    J Clin Psychiatry; 2010 Mar; 71(3):280-6. PubMed ID: 19895779
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A naturalistic, observational study of outpatients with schizophrenia: efficacy and safety results after 6 months. The International Schizophrenia Outpatient Health Outcomes study, IC-SOHO].
    István S; Agoston T; Tamás T; Zoltán J
    Neuropsychopharmacol Hung; 2007 Oct; 9(3):115-24. PubMed ID: 18399029
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictors of subjective and objective quality of life in outpatients with schizophrenia.
    Yamauchi K; Aki H; Tomotake M; Iga J; Numata S; Motoki I; Izaki Y; Tayoshi S; Kinouchi S; Sumitani S; Tayoshi S; Takikawa Y; Kaneda Y; Taniguchi T; Ishimoto Y; Ueno S; Ohmori T
    Psychiatry Clin Neurosci; 2008 Aug; 62(4):404-11. PubMed ID: 18778437
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quality of life in community-dwelling patients with schizophrenia in China.
    Xiang YT; Hou YZ; Yan F; Dixon LB; Ungvari GS; Dickerson F; Li WY; Li WX; Zhu YL; Chan SS; Lee EH; Chiu HF
    J Nerv Ment Dis; 2012 Jul; 200(7):584-7. PubMed ID: 22759934
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship between depressive symptoms and quality of life in Nigerian patients with schizophrenia.
    Akinsulore A; Aloba OO; Mapayi BM; Oloniniyi IO; Fatoye FO; Makanjuola RO
    Soc Psychiatry Psychiatr Epidemiol; 2014 Aug; 49(8):1191-8. PubMed ID: 24549838
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clozapine prescription and quality of life in Chinese patients with schizophrenia treated in primary care.
    Hou CL; Cai MY; Ma XR; Zang Y; Jia FJ; Lin YQ; Chiu HF; Ungvari GS; Ng CH; Zhong BL; Cao XL; Li Y; Shinfuku N; Xiang YT
    Pharmacopsychiatry; 2015 Sep; 48(6):200-4. PubMed ID: 26244858
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Quality of life in patients with schizophrenia: a study of 100 cases].
    Zouari L; Thabet JB; Elloumi Z; Elleuch M; Zouari N; Maâlej M
    Encephale; 2012 Apr; 38(2):111-7. PubMed ID: 22516268
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Attitudes of schizophrenia outpatients toward psychiatric medications: relationship to clinical variables and insight.
    Freudenreich O; Cather C; Evins AE; Henderson DC; Goff DC
    J Clin Psychiatry; 2004 Oct; 65(10):1372-6. PubMed ID: 15491241
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antipsychotics and the quality of life of schizophrenic patients.
    Loga-Zec S; Loga S
    Psychiatr Danub; 2010 Dec; 22(4):495-7. PubMed ID: 21169888
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lack of extrapyramidal side effects predicts quality of life in outpatients treated with clozapine or with typical antipsychotics.
    Strejilevich SA; Palatnik A; Avila R; Bustin J; Cassone J; Figueroa S; Gimenez M; de Erausquin GA
    Psychiatry Res; 2005 Feb; 133(2-3):277-80. PubMed ID: 15741003
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictive value of symptoms for quality of life in first-episode schizophrenia.
    Chugh PK; Rehan HS; Unni KE; Sah RK
    Nord J Psychiatry; 2013 Jun; 67(3):153-8. PubMed ID: 22587635
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomized, 1-year follow-up study of olanzapine and risperidone in the treatment of negative symptoms in outpatients with schizophrenia.
    Alvarez E; Ciudad A; Olivares JM; Bousoño M; Gómez JC
    J Clin Psychopharmacol; 2006 Jun; 26(3):238-49. PubMed ID: 16702888
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quality of life outcomes of risperidone, olanzapine, and typical antipsychotics among schizophrenia patients treated in routine clinical practice: a naturalistic comparative study.
    Ritsner M; Gibel A; Perelroyzen G; Kurs R; Jabarin M; Ratner Y
    J Clin Psychopharmacol; 2004 Dec; 24(6):582-91. PubMed ID: 15538118
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Side-effects of antipsychotic medication and health-related quality of life in schizophrenia.
    Bebbington PE; Angermeyer M; Azorin JM; Marwaha S; Marteau F; Toumi M
    Acta Psychiatr Scand Suppl; 2009; (438):22-8. PubMed ID: 19132963
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antipsychotic treatment in older schizophrenia patients with extrapyramidal side effects in Asia (2001 - 2009).
    Xiang YT; Kreyenbuhl J; Dickerson FB; Ungvari GS; Wang CY; Si TM; Lee EH; Chiu HF; Lai KY; He YL; Yang SY; Chong MY; Tan CH; Kua EH; Fujii S; Sim K; Yong MK; Trivedi JK; Chung EK; Udomratn P; Chee KY; Sartorius N; Shinfuku N
    Int J Clin Pharmacol Ther; 2012 Jul; 50(7):500-4. PubMed ID: 22541750
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuroleptic prescription for Chinese schizophrenics in Hong Kong.
    Chiu H; Lee S; Leung CM; Wing YK
    Aust N Z J Psychiatry; 1992 Jun; 26(2):262-4. PubMed ID: 1353673
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Compliance in schizophrenia: psychopathology, side effects, and patients' attitudes toward the illness and medication.
    Rettenbacher MA; Hofer A; Eder U; Hummer M; Kemmler G; Weiss EM; Fleischhacker WW
    J Clin Psychiatry; 2004 Sep; 65(9):1211-8. PubMed ID: 15367047
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quality of life in patients with schizophrenia: A 2-year cohort study in primary mental health care in rural China.
    He XY; Migliorini C; Huang ZH; Wang F; Zhou R; Chen ZL; Xiao YN; Wang QW; Wang SB; Harvey C; Hou CL
    Front Public Health; 2022; 10():983733. PubMed ID: 36159297
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of Antipsychotic Dose Reduction in Late-Life Schizophrenia: A Prospective Dopamine D2/3 Receptor Occupancy Study.
    Graff-Guerrero A; Rajji TK; Mulsant BH; Nakajima S; Caravaggio F; Suzuki T; Uchida H; Gerretsen P; Mar W; Pollock BG; Mamo DC
    JAMA Psychiatry; 2015 Sep; 72(9):927-34. PubMed ID: 26131622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.